Search - tctmd.com

Displaying 161 - 180 of 261

Sort: Relevancy | Date

News Features

Denervación Renal 2.0: Marcando el Camino de la Recuperación Tras el Symplicity HTN-3

June 24, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

May 12, 2014

News Daily News

Renal Denervation Shows Promise in Patients Refractory to Stenting

L.A. McKeown

May 02, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit

April 02, 2014

News Conference News ACC 2014

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

Yael L. Maxwell

March 29, 2014

News Industry News

ANTI-CLOTTING AGENT HELPS REDUCE THE INCIDENCE AND IMPACT OF STENT THROMBOSIS DURING PERCUTANEOUS CORONARY INTERVENTION

March 27, 2014

News Daily News

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Yael L. Maxwell

February 17, 2014

News Industry News

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

January 08, 2014

News Industry News

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

October 28, 2013

News Daily News

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Caitlin E. Cox

October 23, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Yael L. Maxwell

August 23, 2013

News Daily News

PLATO: 与氯吡格雷相比替卡格雷可以全面减少ACS患者支架内血栓形成

Caitlin E. Cox

August 12, 2013

News Daily News

PLATO: Ticagrelor Lowers Stent Thrombosis vs. Clopidogrel Across the Board in ACS

Caitlin E. Cox

August 12, 2013

News Daily News

PLATO: En Líneas Generales, el Ticagrelor Reduce la Trombosis del Stent frente al Clopidogrel en el Tratamiento del SCA

Caitlin E. Cox

August 12, 2013

News Daily News

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

July 19, 2013

Advertisement

Denervación Renal 2.0: Marcando el Camino de la Recuperación Tras el Symplicity HTN-3

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

Renal Denervation Shows Promise in Patients Refractory to Stenting

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

ANTI-CLOTTING AGENT HELPS REDUCE THE INCIDENCE AND IMPACT OF STENT THROMBOSIS DURING PERCUTANEOUS CORONARY INTERVENTION

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

PLATO: 与氯吡格雷相比替卡格雷可以全面减少ACS患者支架内血栓形成

PLATO: Ticagrelor Lowers Stent Thrombosis vs. Clopidogrel Across the Board in ACS

PLATO: En Líneas Generales, el Ticagrelor Reduce la Trombosis del Stent frente al Clopidogrel en el Tratamiento del SCA

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content